Breast Cancer Trial, Recruiting NCT06830083 Sponsor: The First Affiliated Hospital with Nanjing Medical University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06830083
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People over 18 years old who have been diagnosed with stage I–III breast cancer (not classified as T4, meaning the tumour has not grown into the chest wall or skin in certain ways)
  • People who have had their entire breast surgically removed, including types of surgery that preserve the skin or nipple
  • People whose treating doctors, following Chinese Anticancer Society guidelines, have determined that radiation therapy is needed after surgery
  • People who have had immediate breast reconstruction surgery at the same time as their breast removal, using either a tissue expander (a temporary implant to stretch the skin) or a permanent implant

Who may not be able to join:

  • People who had reconstruction using their own body tissue (such as a flap taken from the back or abdomen) rather than an implant
  • People whose cancer is classified as T4 (either by clinical assessment or confirmed by pathology), meaning the tumour has spread into the chest wall or skin in certain ways
  • People who need radiation treatment on both sides of the chest
  • People who have previously received radiation therapy to the chest area
  • People who are pregnant or currently breastfeeding
  • People who are already taking part in another clinical drug trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-025-68307676

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 January 2025
Est. completion
30 December 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Major complication

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov